Jeffrey P. George, Director at LENZ Therapeutics, Inc. (LENZ), bought 11,184 shares at $8.92 ($100K) on 2026-03-27, disclosed to the SEC on 2026-03-30.
Director Jeffrey P. George purchased 5,592 shares at $8.92 on March 27, 2026, marking the largest insider purchase of his career. This move comes as the stock has crashed nearly 49% over the last 90 days, potentially signaling confidence in the biotech's turnaround.
The stock is trading at $8.29, down 48.57% over the last 90 days and 67.67% over the past year, putting it just 0.48% above its 52-week low of $8.25.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.92 | 5,592 | $50K | 50.0% |
| 2 | $8.92 | 5,592 | $50K | 50.0% |
| Total | $8.92 avg | 11,184 | $100K | 100% |